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Abstract
Background: Although initial presentation of sarcomas in the head and neck region is relatively
common, involvements of the larynx by rhabdomyosarcoma either primary or metastatic have
been reported rarely.
Case report: A case of rhabdomyosarcoma in the right thigh, which involved laryngeal structures
three years after the diagnosis, is presented.
Conclusions: The laryngeal involvement by primary and metastatic rhabdosarcomas is very rare,
however when it occurs it can result in life treating upper airway obstruction. After emergency
intervention, radiotherapy and / or chemotherapy must be undertaken for long-term benefit and
surgery may be helpful only in selected cases.
Introduction
Laryngeal cancer is an important cause of morbidity and
mortality in smokers accounting for 25% of the head and
neck cancers [1]. Over 95 percent of the cancers of the lar-
ynx are of squamous histology. Non-squamous histology
including sarcomas and salivary gland tumors are quite
rare. Primary involvement of the larynx by mesenchymal
tumors has been reported as case reports [2,3]. Metastasis
to the larynx from a neoplasia elsewhere is even rare, mak-
ing 0.09 % to 0.4 % of total [4]. Until present, about 150
metastatic cancers of larynx of various histology have
been reported. Here, we report a case of rhabdomyosar-
coma in the right thigh, which involved laryngeal struc-
tures three years after the diagnosis.
Case Report
A 45 year-old man presented with a complaint of a lump
in the inner side of the right thigh for the past 2 months.
Excision biopsy was performed. Histologically the tumor
was composed of sheets of malignant round and spindled
cells in a variably myxoid stroma. Some cells had abun-
dant eosinophilic cytoplasm. Atypical mitotic figures were
seen (Figure 1). Immunohistochemical stains revealed
that the tumor cells were positive for vimentin, desmin
and myod1. With a diagnosis of rhabdomyosarcoma
combination chemotherapy with ifosfamide (2500 mg/
m2 for 3 days, together with mesna at the same doses) and
adriamycine (60 mg/m2 on day 1) was given for six cycles
as adjuvant treatment. Five months following completion
of chemotherapy, a hemipelvectomy was performed upon
local recurrence of the tumor in the previous location. The
pathological examination was consistent with
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rhabdomyosarcoma. The DICE (dexamethasone, ifosfa-
mide, carboplatin and etoposide) combination adjuvant
chemotherapy was started. However, it had to be stopped
after the 3rd cycle due to elevation of aminotransferases as
high as 5 times the upper limit of normal ranges. After
almost a year of uneventful period, a 3 cm metastatic nod-
ule in the superior segment of left lower lobe was discov-
ered and metastatectomy was performed. The
histopathological examination was consistent with malig-
nant mesenchymal tumor. He had received a total 4
courses of ifosfamide at the dose of a total of 14 g/m2 in 7
days with hematopoietic growth factor support every
month. Four months after the last course he began to
experience hoarseness and mild dyspnea. Physical exami-
nation showed multiple polypoid masses in the sub-glot-
tic region. Magnetic resonance images of head and neck
were showed the laryngeal masses (Figure 2). Biopsy
revealed rhabdomyosarcoma. As the curative surgery was
not feasible, palliative radiotherapy was given to relieve
his symptoms. He experienced only a mild throat pain
during radiotherapy. However, 2 months later he noticed
a mass of an almond size in his mouth. On inspection of
oral cavity, a 3 cm mass just between left tonsil and
tongue, covered with a necrotic pseudomembrane, was
discovered. Excisional biopsy showed rhabdomyosar-
coma. CT of head and region disclosed several other met-
astatic lesions. He was re-admitted to hospital 7 days after
following his last discharge with acute severe dyspnea and
wheezing. His complaints responded well to dexametha-
sone 16 mg/day. Palliative chemotherapy with VAC (vin-
cristine, actinomycine, cyclophosphamide) every week
was started. After the 1st cycle, the mass in the floor of
mouth disappeared.
Discussion
Rhabdomyosarcoma is a tumor of striated muscle. It has
mainly two subtypes: Embryonel and alveolar. While the
loss of heterozygosity of chromosome 11p15 identifies
the first one, latter is characterized by the translocation
t(2;13) (q35;q14) [5]. It is the most common malignant
mesenchymal tumor in children. Therefore most of the
information is inspired from pediatric studies. It is quiet
rare in adults. The most common site of presentation is
head and neck region (35 %). Lungs, bone marrow,
bones, liver and brain are among the most common sites
of metastases [5]. Ifosfamide, adriamycin, etoposide, vin-
cristine and actinomycin are among effective agents in the
treatment of soft tissue sarcomas [6–9]. Survival ranges
from 30% in patients with metastatic presentation to 80%
in those where the disease is localized and complete resec-
tion is performed [7].
Upper airway obstruction, irrespective of the cause, is an
emergency. Therefore it is a must to intervene rapidly.
Corticosteroids may be beneficial by relieving accompa-
nying edema. However immediate tracheotomy can be
required and when necessary should be performed
undoubtedly. After emergency intervention, palliative
measures like radiotherapy and / or chemotherapy must
be undertaken for long-term benefit. However surgery
may be helpful only in selected cases.
Although it is difficult to make the distinction between
metastatic or primary for sure, we supposed our case was
a metastatic invasion rather than primary in an adult
owing to previous diagnosis of rhabdomyosarcoma, sim-
ilar histology and multiplicity of the tumor and rarity of
primary involvement of larynx in adults [4].
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